ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,749.00
0.35%
S&P ASX All Technology
3,067.50
0.14%
Brent Oil
82.585
0.00%
US Dollar vs AUD
1.50761
0.00%
Bitcoin
61,028.05
0.38%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Equillium Inc (EQ)

  7. Equillium Inc (EQ) News

EQ

Equillium (EQ)

Equillium Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EQ
DateTimeSourceHeadlineSymbolCompany
10/05/202406:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EQEquillium Inc
10/05/202406:01Business WireEquillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical HighlightsNASDAQ:EQEquillium Inc
07/05/202422:00Business WireEquillium Announces Poster Presentation at the Annual Meeting of The American Association of ImmunologistsNASDAQ:EQEquillium Inc
03/04/202423:00Business WireEquillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EQEquillium Inc
01/04/202423:00Business WireEquillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus NephritisNASDAQ:EQEquillium Inc
26/03/202407:01Business WireEquillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical HighlightsNASDAQ:EQEquillium Inc
22/03/202423:00Business WireEquillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational ConferenceNASDAQ:EQEquillium Inc
09/03/202409:35Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EQEquillium Inc
09/03/202408:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
24/02/202409:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
24/02/202409:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EQEquillium Inc
22/02/202422:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
04/01/202410:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQEquillium Inc
04/01/202410:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQEquillium Inc
04/01/202410:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQEquillium Inc
22/12/202300:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
22/12/202300:00Business WireEquillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac DiseaseNASDAQ:EQEquillium Inc
21/11/202303:23PR Newswire (US)EQ Bank Card launches in Québec as Carte Banque EQNASDAQ:EQEquillium Inc
21/11/202303:23PR Newswire (Canada)EQ Bank Card launches in Québec as Carte Banque EQNASDAQ:EQEquillium Inc
14/11/202301:00Business WireEquillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of RheumatologyNASDAQ:EQEquillium Inc
09/11/202308:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EQEquillium Inc
09/11/202308:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
09/11/202308:01Business WireEquillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical UpdatesNASDAQ:EQEquillium Inc
07/11/202300:00Business WireEquillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of NephrologyNASDAQ:EQEquillium Inc
19/10/202323:00Business WireEquillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of RheumatologyNASDAQ:EQEquillium Inc
16/10/202323:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
16/10/202323:00Business WireEquillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics SymposiumNASDAQ:EQEquillium Inc
06/10/202308:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
06/10/202308:23Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EQEquillium Inc
03/10/202323:00Business WireEquillium to Host Analyst & Investor DayNASDAQ:EQEquillium Inc
 Showing the most relevant articles for your search:NASDAQ:EQ

Your Recent History

ASX
NAB
National Australia Bank
NYSE
MCD
McDonalds
FX
EURAUD
Euro vs AUD
ASX
MQG
Macquarie
NYSE
NKE
Nike
ASX
XMM
S&P ASX 300 Metals and M...
NASDAQ
NVDA
NVIDIA
ASX
CSL
CSL
NASDAQ
TSLA
Tesla
ASX
XFL
S&P ASX 50
NASDAQ
AAPL
Apple
FX
GBPAUD
Sterling vs AUD
ASX
NCM
Newcrest Mining
ASX
FMG
Fortescue
ASX
QBE
QBE Insurance
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved